Incidence of dry eye disease in India is about 1.9 million. The prevalence of dry eye disease will be about 40% of the urban population by 2030. Men get it as early as in their 20s and 30s while women get it in their 50s and 60s. Dry eye disease caused due to inadequate tear … Continue reading India on the brink of dry eye disease epidemic
L V Prasad Eye Institute
TB infection in the eye can lead to autoimmunity
Researchers from L V Prasad Eye Institute have for the first time found evidence of how TB infection of the eye leads to autoimmunity causing widespread disease of the eye (uveitis). TB infection damages the blood-retinal barrier allowing blood to reach the retina. Once inside the eye, autoimmune cells specifically target the retina where they … Continue reading TB infection in the eye can lead to autoimmunity
Hyderabad researchers grow miniature eyes using stem cells
Researchers at the Hyderabad-based L.V. Prasad Eye Institute (LVPEI) have successfully grown miniature eye-like organs that closely resemble the developing eyes of an early-stage embryo. The miniature eyes were produced using induced pluripotent stem (iPS) cells. The iPS cells are produced by genetically manipulating human skin cells to produce embryonic-like stem cells that are capable … Continue reading Hyderabad researchers grow miniature eyes using stem cells
Indian researchers’ novel approach to early diagnosis of retinal diseases
Early diagnosis of certain eye diseases and studying the early progression of the diseases has now become possible, thanks to the work carried out by a team of researchers from three institutes — IISER in Kolkata, L.V. Prasad Eye Institute in Hyderabad and BARC in Visakhapatnam. The researchers used the retinal data captured by a … Continue reading Indian researchers’ novel approach to early diagnosis of retinal diseases
Working towards personalised TB treatment
Three major global research centres in India will receive funding coming out of collaboration between the UK Medical Research Council (MRC) and the Department for Biotechnology (DBT), India. The Department for Biotechnology will match the funding provided by UK through MRC and Newton Fund. The Chennai-based National Institute for Research in Tuberculosis (NIRT) will get … Continue reading Working towards personalised TB treatment
Trials soon to test treatment for blindness due to chemical burns
Published in The Hindu on December 19, 2012 “It is a disruptive technology for treating blindness caused by chemical burns,’ said Dr. Virender S. Sangwan, Associate Director, Clinical Research at the L.V. Prasad Eye Institute, Hyderabad. “We anticipate starting the human clinical trials to test the safety and efficacy of the technology by mid 2013.” … Continue reading Trials soon to test treatment for blindness due to chemical burns
Novel technique using stem cells revives damaged eye
Published in The Hindu on March 1, 2012 Treating blindness caused by burns using limbal stem cells harvested from the undamaged eye of the same patient has now become cheaper, easier and safer. Results of a pilot study of the SLET (simplified technique of limbal transplantation) technique conducted at L.V. Prasad Eye Institute on six … Continue reading Novel technique using stem cells revives damaged eye
A step closer to restoring vision using embryonic-like stem cells
Published in The Hindu on September 10, 2009 After establishing a procedure to restore vision of people whose cornea has been damaged by physical or chemical injury by harvesting limbal stem cells from the healthy eye and transplanting them to the eye that has been damaged, the Hyderabad-based LV Prasad Eye Institute has moved to … Continue reading A step closer to restoring vision using embryonic-like stem cells
Science Chronicle 